HK1107522A1 - Taste masking system for non-plasticizing drugs - Google Patents
Taste masking system for non-plasticizing drugsInfo
- Publication number
- HK1107522A1 HK1107522A1 HK07113052.1A HK07113052A HK1107522A1 HK 1107522 A1 HK1107522 A1 HK 1107522A1 HK 07113052 A HK07113052 A HK 07113052A HK 1107522 A1 HK1107522 A1 HK 1107522A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- taste masking
- masking system
- plasticizing drugs
- usp
- api
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64180705P | 2005-01-06 | 2005-01-06 | |
US64261905P | 2005-01-10 | 2005-01-10 | |
PCT/US2006/000118 WO2006074185A2 (fr) | 2005-01-06 | 2006-01-04 | Systeme de masquage de gout pour des medicaments non plastifiants |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1107522A1 true HK1107522A1 (en) | 2008-04-11 |
Family
ID=36648121
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07113052.1A HK1107522A1 (en) | 2005-01-06 | 2007-11-29 | Taste masking system for non-plasticizing drugs |
HK10102128.9A HK1135612A1 (en) | 2005-01-06 | 2010-03-01 | Taste masking system for non-plasticizing drugs |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10102128.9A HK1135612A1 (en) | 2005-01-06 | 2010-03-01 | Taste masking system for non-plasticizing drugs |
Country Status (11)
Country | Link |
---|---|
US (3) | US20060147516A1 (fr) |
EP (2) | EP2098225B8 (fr) |
JP (1) | JP4995099B2 (fr) |
AT (2) | ATE500822T1 (fr) |
CA (1) | CA2593016C (fr) |
DE (2) | DE602006020642D1 (fr) |
DK (1) | DK1830814T3 (fr) |
ES (1) | ES2325599T3 (fr) |
HK (2) | HK1107522A1 (fr) |
MX (1) | MX2007008320A (fr) |
WO (1) | WO2006074185A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2098225B8 (fr) * | 2005-01-06 | 2011-06-22 | Cima Labs Inc. | Système de masquage de goût pour médicaments non plastifiés |
US20080124387A1 (en) * | 2006-11-27 | 2008-05-29 | Kapac, Llc | Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients |
JP5242576B2 (ja) * | 2007-08-27 | 2013-07-24 | 旭化成ケミカルズ株式会社 | 結晶セルロース及び顆粒含有錠の製造方法 |
WO2010077878A1 (fr) * | 2008-12-15 | 2010-07-08 | Fleming And Company, Pharmaceuticals | Formulation de vitamines se dissolvant rapidement et procédés d'utilisation de celle-ci |
WO2012148432A1 (fr) | 2011-04-28 | 2012-11-01 | Acme Specialty Products, Llc | Compositions de masquage du goût et leurs formes comestibles |
KR20140057604A (ko) | 2011-08-12 | 2014-05-13 | 베링거잉겔하임베트메디카게엠베하 | 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE418247B (sv) * | 1975-11-17 | 1981-05-18 | Haessle Ab | Sett att framstella kroppar med reglerad frigoring av en aktiv komponent |
US4747881A (en) * | 1985-02-05 | 1988-05-31 | Warner-Lambert Company | Ingestible aggregate and delivery system prepared therefrom |
US4874613A (en) * | 1987-03-06 | 1989-10-17 | Baker Cummins Pharmaceuticals, Inc. | Taste concealing pharmaceutical dosage unit |
US4851226A (en) * | 1987-11-16 | 1989-07-25 | Mcneil Consumer Products Company | Chewable medicament tablet containing means for taste masking |
US5234957A (en) | 1991-02-27 | 1993-08-10 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
DE68916497T2 (de) * | 1988-09-30 | 1994-11-17 | Rhone Poulenc Rorer Ltd | Pharmazeutisches Granulat. |
US4966770A (en) * | 1989-07-26 | 1990-10-30 | Himedics, Inc. | Prednisone microencapsulated granules |
US5223264A (en) * | 1989-10-02 | 1993-06-29 | Cima Labs, Inc. | Pediatric effervescent dosage form |
US5178878A (en) * | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
US5464632C1 (en) * | 1991-07-22 | 2001-02-20 | Prographarm Lab | Rapidly disintegratable multiparticular tablet |
AU715867B2 (en) * | 1997-01-06 | 2000-02-10 | Pfizer Inc. | Rapidly releasing and taste-masking pharmaceutical dosage form |
US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
EP1688131A1 (fr) * | 1998-08-12 | 2006-08-09 | Cima Labs Inc. | Comprimé se désaggregeant dans la bouche pour former une pulpe visqueuse |
US6368625B1 (en) * | 1998-08-12 | 2002-04-09 | Cima Labs Inc. | Orally disintegrable tablet forming a viscous slurry |
EP1133282A4 (fr) * | 1998-11-25 | 2006-03-29 | Cima Labs Inc | Systeme d'enrobage a liberation rapide masquant le gout |
US6464632B1 (en) * | 1999-02-13 | 2002-10-15 | James M. Taylor | Flexible inner liner for the working channel of an endoscope |
GB9904629D0 (en) * | 1999-03-02 | 1999-04-21 | Danbiosyst Uk | Oral drug delivery system |
CA2401424C (fr) * | 2000-03-28 | 2011-02-08 | Farmarc Nederland Bv | Complexes d'inclusion d'alprazolame et compositions pharmaceutiques les contenant |
GB0027357D0 (en) * | 2000-11-09 | 2000-12-27 | Bradford Particle Design Plc | Particle formation methods and their products |
US20030143272A1 (en) * | 2001-03-14 | 2003-07-31 | Waterman Kenneth C. | Pharmaceutical tablet and process for making thereof |
CA2447693A1 (fr) * | 2001-05-31 | 2002-12-05 | Cima Labs Inc. | Masquage du gout de medicaments hautement hydrosolubles |
FR2837100B1 (fr) * | 2002-03-18 | 2004-07-23 | Flamel Tech Sa | Comprimes a bases de microcapsules a liberation modifiee |
RU2005109909A (ru) * | 2002-09-04 | 2006-10-10 | Рэнбакси Лабораториз Лимитед (In) | Лекарственные формы с замаскированным вкусом и способы их получения |
CA2511963A1 (fr) * | 2002-12-31 | 2004-07-22 | Larry L. Augsburger | Procede pour la fabrication de formes posologiques de produits pharmaceutiques contenant des composants agissant comme un rembourrage protecteur |
US20050232977A1 (en) * | 2004-04-20 | 2005-10-20 | Khan Sadath U | Metered mixing technology for improved taste masking |
EP2098225B8 (fr) * | 2005-01-06 | 2011-06-22 | Cima Labs Inc. | Système de masquage de goût pour médicaments non plastifiés |
-
2006
- 2006-01-04 EP EP09007900A patent/EP2098225B8/fr not_active Not-in-force
- 2006-01-04 US US11/325,038 patent/US20060147516A1/en not_active Abandoned
- 2006-01-04 MX MX2007008320A patent/MX2007008320A/es active IP Right Grant
- 2006-01-04 WO PCT/US2006/000118 patent/WO2006074185A2/fr active Application Filing
- 2006-01-04 DE DE602006020642T patent/DE602006020642D1/de active Active
- 2006-01-04 DK DK06717339T patent/DK1830814T3/da active
- 2006-01-04 CA CA2593016A patent/CA2593016C/fr not_active Expired - Fee Related
- 2006-01-04 JP JP2007550427A patent/JP4995099B2/ja not_active Expired - Fee Related
- 2006-01-04 AT AT09007900T patent/ATE500822T1/de not_active IP Right Cessation
- 2006-01-04 EP EP06717339A patent/EP1830814B1/fr not_active Not-in-force
- 2006-01-04 AT AT06717339T patent/ATE435009T1/de not_active IP Right Cessation
- 2006-01-04 DE DE602006007538T patent/DE602006007538D1/de active Active
- 2006-01-04 ES ES06717339T patent/ES2325599T3/es active Active
- 2006-01-04 US US11/325,673 patent/US20060147517A1/en not_active Abandoned
-
2007
- 2007-11-29 HK HK07113052.1A patent/HK1107522A1/xx not_active IP Right Cessation
-
2010
- 2010-03-01 HK HK10102128.9A patent/HK1135612A1/xx not_active IP Right Cessation
-
2014
- 2014-10-07 US US14/507,982 patent/US20150050336A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1830814A2 (fr) | 2007-09-12 |
DE602006007538D1 (de) | 2009-08-13 |
DE602006020642D1 (de) | 2011-04-21 |
WO2006074185A2 (fr) | 2006-07-13 |
ES2325599T3 (es) | 2009-09-09 |
US20060147517A1 (en) | 2006-07-06 |
JP2008526853A (ja) | 2008-07-24 |
EP1830814A4 (fr) | 2008-04-02 |
EP1830814B1 (fr) | 2009-07-01 |
EP2098225B1 (fr) | 2011-03-09 |
DK1830814T3 (da) | 2009-08-03 |
CA2593016A1 (fr) | 2006-07-13 |
ATE435009T1 (de) | 2009-07-15 |
EP2098225A2 (fr) | 2009-09-09 |
EP2098225B8 (fr) | 2011-06-22 |
CA2593016C (fr) | 2012-05-15 |
WO2006074185A3 (fr) | 2006-09-08 |
HK1135612A1 (en) | 2010-06-11 |
US20060147516A1 (en) | 2006-07-06 |
ATE500822T1 (de) | 2011-03-15 |
MX2007008320A (es) | 2007-09-07 |
US20150050336A1 (en) | 2015-02-19 |
EP2098225A3 (fr) | 2009-10-21 |
JP4995099B2 (ja) | 2012-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1135612A1 (en) | Taste masking system for non-plasticizing drugs | |
NO20073802L (no) | Leuprolidacetat og acetylkolinsteraseinhibitor eller NMDA-reseptorantagonister for behandlingen av Alzheimers sykdom | |
TW200716208A (en) | Modified and immediate release memantine bead formulation | |
ATE474487T1 (de) | Vorrichtung zur herstellung eines aufgebrühten aromatischen getränks | |
SG165373A1 (en) | Oral dosage form comprising an antimisuse system | |
ES2659390T3 (es) | Pastilla para chupar para uso en la reducción de la dependencia del tabaco y/o del alcohol | |
WO2007084221A9 (fr) | Procédés et appareil pour l'identification de matière dans des données de visualisation | |
MY161079A (en) | Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic | |
EP2135603A3 (fr) | Compositions et procédés pour augmenter la sensibilité à l'insuline | |
TNSN08284A1 (en) | Masking the taste of powders | |
EP3311801A3 (fr) | Émulsions gélifiées à croquer | |
MX2010009844A (es) | Procedimientos, formas farmaceuticas, y kits para administrar ziprasidona sin alimento. | |
UA90893C2 (ru) | Пероральная дозированная форма производных гемцитабина | |
NZ599292A (en) | Vitamin d compositions and method of administration to a human being | |
PL2205279T3 (pl) | Farmaceutyczna kombinacja aliskirenu i walsartanu | |
UA102254C2 (ru) | Жидкий состав для деферипрона с приятным вкусом | |
EP1262196A3 (fr) | Combinaison d'un inhibiteur de la recapture de monoamines et d'un antagoniste opioique pour l'utilisation dans l'alcoolisme et la dépendance alcoolique | |
HK1120417A1 (en) | Stable nanoparticle formulations | |
HUP0102159A2 (hu) | Készítmény savtúltengés kezelésére | |
MXPA05008902A (es) | Soluciones de drogas en mentol. | |
TW200611697A (en) | Generally linear effervescent oral fentanyl dosage form and methods of administering | |
WO2006023295A3 (fr) | Compositions pharmaceutiques comprenant des agents effervescents et un fenofibrate | |
MX2007004787A (es) | Complejo que comprende mequitazina, una ciclodextrina y un agente de interaccion. | |
WO2005115110A3 (fr) | Formes pharmaceutiques orales | |
WO2009094181A8 (fr) | Nanostructures sensibles au ph |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20200107 |